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Caveolin-1, a structural protein of caveolae, is cleared unusually slowly from the Golgi apparatus during biosynthetic
transport. Furthermore, several caveolin-1 mutant proteins accumulate in the Golgi apparatus. We examined this behavior
further in this mutant study. Golgi accumulation probably resulted from loss of Golgi exit information, not exposure of
cryptic retention signals, because several deletion mutants accumulated in the Golgi apparatus. Alterations throughout
the protein caused Golgi accumulation. Thus, most probably acted indirectly, by affecting overall conformation, rather
than by disrupting specific Golgi exit motifs. Consistent with this idea, almost all the Golgi-localized mutant proteins
failed to oligomerize normally (even with an intact oligomerization domain), and they showed reduced raft affinity in an
in vitro detergent-insolubility assay. A few mutant proteins formed unstable oligomers that migrated unusually slowly
on blue native gels. Only one mutant protein, which lacked the first half of the N-terminal hydrophilic domain,
accumulated in the Golgi apparatus despite normal oligomerization and raft association. These results suggested that
transport of caveolin-1 through the Golgi apparatus is unusually difficult. The conformation of caveolin-1 may be
optimized to overcome this difficulty, but remain very sensitive to mutation. Disrupting conformation can coordinately
affect oligomerization, raft affinity, and Golgi exit of caveolin-1.

INTRODUCTION
Caveolin-1 is an important component of the membraneembedded coat that surrounds caveolae (Rothberg et al.,
1992; Fra et al., 1994; Smart et al., 1999; Fernandez et al., 2002).
Although it is an integral membrane protein, caveolin-1
lacks conventional transmembrane domains. Instead, Nand C-terminal hydrophilic domains flank a central 33-residue hydrophobic domain (Smart et al., 1999). Both hydrophilic domains are located on the cytoplasmic side of the
plasma membrane, and the hydrophobic domain has been
suggested to form a helical hairpin embedded in the bilayer.
A peptide corresponding to the last 20 residues of the
N-terminal hydrophilic domain, a region named the caveolin scaffolding domain (CSD), can bind to membranes independently (Schlegel et al., 1999), at least in part because of
the high number of aromatic residues in this domain (Arbuzova et al., 2000). The C-terminal domain also can associArticle published online ahead of print. Mol. Biol. Cell 10.1091/
mbc.E04 – 06 – 0480. Article and publication date are available at
www.molbiolcell.org/cgi/doi/10.1091/mbc.E04 – 06 – 0480.
‡

Corresponding author. E-mail address: deborah.brown@sunysb.edu.

Abbreviations used: CSD, caveolin scaffolding domain; DOPC, dioleoyl phosphatidylcholine; DPPC, dipalmitoyl phosphatidylcholine;
DRM, detergent-resistant membrane; FRT, Fischer rat thyroid; HRP,
horseradish peroxidase; IF, immunofluorescence; OG, N-octyl-␤-Dglucopyranoside; PBS, phosphate-buffered saline; PLAP, placental
alkaline phosphatase; TX100, Triton X-100.
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ate with membranes independently, at least in part via three
palmitate chains (Luetterforst et al., 1999).
Caveolin-1, alone or with the related protein caveolin-2,
forms large (⬎400 kDa), SDS-stable oligomers (Monier et al.,
1995; Sargiacomo et al., 1995; Scheiffele et al., 1998). These
oligomers are thought to associate with each other to form
the filamentous structure of the caveolar coat (Fernandez et
al., 2002). Oligomerization occurs soon after synthesis
(Scheiffele et al., 1998). It is not known where along the
secretory pathway caveolin oligomers assemble into caveolae, although pits with the distinctive morphology of caveolae have only been reported at the plasma membrane (Rothberg et al., 1992; Denker et al., 1996). Residues 60 –100 of
caveolin-1 contain the oligomerization domain (Sargiacomo
et al., 1995; Schlegel and Lisanti, 2000). However, changes
outside this domain can block oligomerization (Machleidt et
al., 2000; Lee et al., 2002), presumably through indirect effects.
Caveolin-1 has a high affinity for lipid rafts, membrane
microdomains that have a high degree of lipid order and are
concentrated in caveolae (Smart et al., 1999). Raft lipids and
proteins are resistant to solubilization by nonionic detergents such as Triton X-100 (TX100) and 3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate, and can be isolated from cell lysates as detergent-resistant membranes
(DRMs; London and Brown, 2000; Schuck et al., 2003; Shogomori and Brown, 2003). DRM association provides a useful
tool for identifying proteins that have a high affinity for rafts
(London and Brown, 2000; Shogomori and Brown, 2003).
Acylation of raft proteins often aids in raft targeting. Caveo-
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Caveolin-1 Mutant Proteins

lin-1 is unusual in that although it is triply acylated, prevention of acylation by mutation does not affect raft affinity
(Dietzen et al., 1995). It is not known how caveolin-1 is
targeted to rafts, although binding of the protein to cholesterol may play a role (Murata et al., 1995; Thiele et al., 2000).
Unlike most plasma membrane proteins, a significant
amount of caveolin-1, estimated at ⬃15% by electron microscopy (Denker et al., 1996) is present in the Golgi apparatus at
steady state (Rothberg et al., 1992; Dupree et al., 1993;
Luetterforst et al., 1999). Although early studies suggested
that caveolin-1 cycled constitutively between caveolae and
the Golgi apparatus (Conrad et al., 1995), this was later
shown not to occur (Nichols, 2002; Thomsen et al., 2002).
Instead, as caveolin-1 is selectively cleared from the Golgi
apparatus when protein synthesis is inhibited with cycloheximide (Nichols, 2002), the Golgi pool may be a biosynthetic intermediate in transit to the plasma membrane. If so,
caveolin-1 exits the Golgi more slowly than most other cargo
proteins, which are not detected in the Golgi apparatus at
steady state.
Several caveolin-1 mutant proteins accumulate in the
Golgi apparatus (Luetterforst et al., 1999; Machleidt et al.,
2000; Lee et al., 2002), as does caveolin-2 when expressed
without caveolin-1 (Mora et al., 1999; Parolini et al., 1999).
Coexpression with caveolin-1 rescues cell-surface expression
of caveolin-2. Golgi accumulation of mutant proteins is unusual, because most proteins accumulate in the endoplasmic
reticulum (ER) through interaction with chaperone proteins
if mutation blocks proper folding. It is not known whether
mutation exposes cryptic Golgi retention signals in caveolin-1 (Luetterforst et al., 1999) or whether it destroys information required for efficient Golgi exit (Machleidt et al.,
2000). We examined a panel of caveolin-1 mutant proteins to
gain more insight into this unusual localization.
MATERIALS AND METHODS
Cells and Antibodies
Culture of COS-1, Fischer rat thyroid (FRT), and mouse melanoma MEB-4
cells has been described previously (Ostermeyer et al., 1999, 2001). The primary antibodies rabbit anti-caveolin-1 and mouse anti-GM130 antibodies
were from BD Transduction Laboratories (San Diego, CA); rabbit anti-placental alkaline phosphatase (PLAP) antibodies were from DakoCytomation California (Carpinteria, CA); and rabbit and mouse (12CA5) anti-hemagglutinin
(HA) epitope antibodies were from Santa Cruz Biotechnology (Santa Cruz,
CA). The secondary antibodies fluorescein isothiocyanate- and Texas Redconjugated goat anti-rabbit IgG, Texas Red-conjugated goat anti-mouse
Ig(G⫹M), and horseradish peroxidase (HRP)-conjugated donkey anti-rabbit
IgG were from Jackson ImmunoResearch Laboratories (West Grove, PA).

Plasmids
Plasmids encoding HA- and myc-tagged canine caveolin-1 (Dietzen et al.,
1995), Cys- (a triple Cys nonpalmitoylated mutant of this protein; Dietzen et
al., 1995), canine caveolin-1 with a C-terminal myc tag followed by the ER
retrieval motif KKSL (Ostermeyer et al., 2001), human PLAP, and PLAP-HA,
containing the extracellular domain of PLAP fused to the transmembrane and
cytoplasmic domains of influenza hemagglutinin (Arreaza and Brown, 1995),
have been described. pSAV2M2, encoding canine caveolin-1 with a C-terminal myc tag followed by green fluorescent protein (GFP), was the gift of S.
Munro (Medical Research Council, Cambridge, United Kingdom). Plasmids
encoding the caveolin-1 mutants 71A75, 76A80, 81A85, 86A90, 91A95, and
96A100 (Machleidt et al., 2000) were gifts of P. Liu and R.G.W. Anderson
(University of Texas Southwestern, Dallas, TX). All other caveolin-1 mutants
were made by mutagenesis of HA- and myc-tagged canine caveolin-1 (Dietzen et al., 1995) by standard polymerase chain reaction or by using the
QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). Amino
acids altered in these mutants are referred to based on their position in
wild-type canine caveolin-1␣ (Kurzchalia et al., 1992). Each of these mutants
contained an N-terminal HA tag. Each contained a C-terminal myc tag, except
the following: Cav-NTD (ending with R101); Y148A5 (Ala substitutions for
residues 148 –152); H153A5 (Ala substitutions for residues 153–157); the Cterminal truncation mutants ⌬13, ⌬21, ⌬31 (named for the number of residues
deleted from the C terminus); and ⌬C (lacking the entire C-terminal domain
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and ending with K135). Cav-⌬N1 lacked residues 3– 48, Cav-⌬CSD lacked
residues 81–100, and Cav-⌬N1/⌬C lacked residues 3– 48 and 136 –178. Cav⌬N2/⌬C lacked residues 46 –100 and 136 –178. Hydrophobic domain Alasubstitution mutants have been described previously (Ostermeyer et al., 2004).
Other mutants are self-explanatory or are described in the figure legends. All
mutations were verified by sequencing, and all mutant proteins migrated as
expected on SDS-PAGE.

Other Reagents
Dipalmitoyl phosphatidylcholine (DPPC), dioleoyl phosphatidylcholine
(DOPC), and cholesterol were from Avanti Polar Lipids (Alabaster, AL).
N-Octyl-␤-d-glucopyranoside (OG) was from Anatrace (Maumee, OH). Polyvinylidene difluoride (PVDF) membrane was from Millipore (Bedford, MA).
X-omat AR film was from Eastman Kodak (Rochester, NY), and Western
Lightning chemiluminescence reagent from PerkinElmer Life and Analytical
Sciences (Boston, MA). Serva Blue G was from Serva (Heidelberg, Germany).
Other reagents were from Sigma-Aldrich (St. Louis, MO).

Transfection and Immunofluorescence
Cells were transfected using Lipofectamine 2000 from Invitrogen (Carlsbad,
CA) as described previously (Ostermeyer et al., 2004). All data were from
transiently transfected cells, harvested 2 d after transfection, except immunofluorescence (IF) images of Ala-scan mutants in and near the CSD (71A75 and
76A80 shown in Figure 7B), where mixed populations of stably transfected
FRT cells expressing each mutant protein were examined.
IF microscopy on paraformaldehyde-fixed, TX100-permeabilized, coverslip-grown cells was as described previously (Ostermeyer et al., 2001). Where
indicated, cells were incubated with 50 g/ml cycloheximide for the indicated times before fixation. Green and red images, obtained with a 100⫻
objective (numerical aperture 1.3), were captured separately into Adobe Photoshop from a SPOT cooled charge-coupled device 24 bit color digital camera
(Diagnostic Instruments, Sterling Heights, MI) mounted on an Axioskop 2
microscope (Carl Zeiss, Oberkochen, Germany).

Reconstitution, Detergent Extraction, and DRM Analysis
For reconstitution of proteins and lipids from cell lysates into mixed liposomes, COS-1 or transfected MEB-4 cells in one 60-mm dish (expected to
contain 400 nmol of membrane lipid; Brown and Rose, 1992) were lysed with
0.7 ml of TNE (25 mM Tris-HCl, 150 mM NaCl, and 5 mM EDTA, pH 7.4)
containing 120 mM OG and protease inhibitors (0.5 g/ml leupeptin, 0.7
g/ml pepstatin, and 0.2 mM phenylmethylsulfonyl fluoride). Lysates were
clarified by ultracentrifugation at 100,000 ⫻ g in a TL-100 tabletop ultracentrifuge (Beckman Coulter, Fullerton, CA) for 10 min. Supernatant (200 l) was
mixed with 0.5 ml of lipids [4 mM, DPPC:cholesterol 2:1 (mol:mol) or DOPC,
as indicated] in TNE containing 180 mM OG. Mixtures were subjected to
dialysis overnight against 5 L phosphate-buffered saline (PBS; 150 mM NaCl
and 20 mM phosphate buffer, pH 7.4) to form mixed proteoliposomes containing cellular proteins and lipids and artificial lipids. Where indicated, the
association of caveolin-1 with these liposomes was analyzed by flotation in
sucrose gradients. To do this, an aliquot of liposomes was brought to 0.5 ml
with PBS, mixed with 1.5 ml of TNE containing 53% sucrose, placed in a 12-ml
ultracentrifuge tube, overlaid with 8 ml of TNE/38% sucrose and then 1 ml of
TNE/5% sucrose, and subjected to ultracentrifugation in an SW41 rotor at
80,000 ⫻ g for 18 h. Three fractions (3.6 ml each) were harvested from the
bottom, and any pelleted material was collected and resuspended in 3.6 ml of
TNE/1% TX100. Proteins in 0.5-ml aliquots of each fraction were collected by
precipitation in trichloroacetic acid in the presence of 10 g of bovine serum
albumin as carrier. Protein pellets were washed once with acetone and once
with diethyl ether, dissolved in gel loading buffer, and analyzed by SDSPAGE and Western blotting.
To analyze DRM association by using sucrose gradients, an aliquot of
liposome suspension was adjusted to 1% TX100 in 0.5 ml by using PBS and a
10% TX100 stock and incubated on ice for 30 min. Sucrose step gradients were
then formed as described above for detergent-free samples and subjected to
sucrose gradient centrifugation, fractionation, SDS-PAGE, and Western blotting as described above. To analyze DRM association without sucrose gradients, after dialysis 0.2 ml of liposome suspension was mixed with 0.9 ml of
TNE and collected by centrifugation at top speed in a Microfuge for 5 min.
Supernatants were discarded and pellets resuspended in 0.5 ml of ice-cold
PBS, adjusted to 1% TX100 with a 10% stock, incubated on ice for 30 min, and
then subjected to ultracentrifugation in standard Microfuge tubes at 48,000
rpm for 30 min in a TLA-100 rotor in a TL-100 tabletop ultracentrifuge.
Supernatants were collected, and pellets resuspended in 0.5 ml of TNE/1%
TX100. Equal volumes of supernatant and pellet fractions were subjected to
SDS-PAGE and Western blotting to visualize the indicated proteins.

Gels and Blots
Blue native PAGE was performed as described previously (Schagger et al.,
1994), with changes as noted next. Cells were lysed in lysis buffer (500 mM
6-amino caproic acid, 2 mM EDTA, and 25 mM Bistris, pH 7.0) containing 120
mM OG for 30 min at 4°C. Lysates were clarified by centrifugation for 10 min
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consisted of dispersed elements (Figure 1, G–L), as seen
previously (Luetterforst et al., 1999). None of the mutant
caveolin-1 proteins examined here had any obvious effect on
Golgi morphology. Golgi staining of caveolin-1, relative to
caveolar staining, gradually declined over a few hours of
cycloheximide treatment (Figure 1, A–L), as reported previously (Nichols, 2002). By contrast, another exogenously expressed plasma membrane protein, PLAP-HA (Arreaza and
Brown, 1995), was usually (⬎90% of transfected cells) undetectable in the Golgi apparatus at steady state (Figure 1M;
GM130 localization in the same cell shown in Figure 1N) and
was never detected there after 1-h incubation with cycloheximide. Thus, caveolin-1 was cleared unusually slowly from
the Golgi apparatus.

Figure 1. Selective clearance of caveolin-1 from the Golgi apparatus in cycloheximide-treated cells. COS (A–F) or FRT cells expressing caveolin-1 (G–L) or PLAP-HA (M and N) were left untreated (A,
D, G, J, M, and N) or treated with cycloheximide (CHX) for 1 h (B,
E, H, and K) or 3 h (C, F, I, and L) before fixation, permeabilization,
and detection of caveolin-1 (A–C and G–I) or PLAP-HA (M) and
GM130 in the same cells (D–F, J–L, and N) by IF.

at top speed in a Microfuge. Supernatants were mixed with 1/10 volume
sample buffer (5% Serva Blue G, 500 mM ⑀-amino n-caproic acid, and 100 mM
Bistris, pH 7.0) and 1/10 volume glycerol. Proteins were separated on linear
5.5–16% acrylamide gradient gels run at 100 V at 4°C until the dye reached the
middle of the gel. Blue cathode buffer (50 mM Tricine, 15 mM Bistris, and
0.02% Serva Blue G, pH 7.0) was then replaced by colorless cathode buffer
(lacking Serva Blue G), and gels were run at 200 V until the dye reached the
bottom. After soaking gels for 10 min at room temperature in transfer buffer
containing 0.1% SDS, proteins were transferred to PVDF membranes and
detected by Western blotting. Sizes were roughly estimated by comparison to
standards: apoferritin (440 kDa), ␤-amylase (200 kDa), bovine serum albumin
(66 kDa), and carbonic anhydrase (29 kDa).
SDS-PAGE, transfer of proteins to PVDF membranes, and Western blotting
were as described previously (Ostermeyer et al., 2004). Caveolin-1 and all
mutant proteins were detected on Western blots with anti-caveolin-1 antibodies and HRP-conjugated secondary antibodies, visualizing bands by enhanced
chemiluminescence. Detergent-insolubility results of different mutants shown
in the same figure did not always come from the same blot. Caveolin-1–
positive bands were all aligned for presentation, although they would not
necessarily have comigrated if analyzed side by side.

RESULTS
Cellular Localization of Caveolin-1
Caveolin-1 was clearly detectable in the Golgi apparatus, as
well as punctate caveolae, in most COS cells (Figure 1A) and
after transient expression in FRT cells, which do not express
endogenous caveolin-1 (Lipardi et al., 1998). The Golgi apparatus in FRT cells was heterogeneous. It had a normal
perinuclear distribution in some cells, but in other cells
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Golgi Accumulation of Caveolin-1 Deletion Mutants
Both the C-terminal domain of caveolin-1, expressed without the rest of the protein, and caveolin-1 lacking the
C-terminal domain, accumulate in the Golgi apparatus
(Luetterforst et al., 1999; Machleidt et al., 2000). These findings suggested that caveolin-1 might contain two Golgitargeting signals; one in the C-terminal domain and the
second in either the N-terminal or hydrophobic domain.
To localize the latter signal more precisely, we expressed
the N-terminal domain of caveolin-1 alone (Cav-NTD). This
protein was largely cytosolic, but it was concentrated in the
Golgi apparatus when membrane association was seen (Figure 2A). To localize the putative signal further, we attempted to express constructs encoding smaller fragments of
the N-terminal domain, but we could not detect the proteins.
As an alternate approach, we made two new constructs,
Cav-⌬N1/⌬C and Cav-⌬N2/⌬C. Each encoded half of the
N-terminal domain, linked to the hydrophobic domain (Figure 2). Surprisingly, both proteins accumulated in the Golgi
apparatus (Figure 2, D and G). In addition to the Golgi
apparatus, Cav-⌬N2/⌬C also accumulated in the ER (Figure
2G), and sometimes in lipid droplets (Figure 2G, arrows),
because it lacked a sequence needed for efficient ER exit
(Machleidt et al., 2000). Caveolin-1 is partially redirected to
lipid droplets when it overaccumulates in the ER (Ostermeyer et al., 2001, 2004). The pool of Cav-⌬N2/⌬C in the
Golgi apparatus probably came from molecules that escaped
lipid droplet targeting, and slowly left the ER via the secretory pathway. Despite the Golgi accumulation of ⌬N1/⌬C,
neither it nor any of the caveolin-1 mutant proteins examined here affected transport of a coexpressed plasma membrane protein, PLAP, to the cell surface (Figure 2, J–O).
It is difficult to explain these and earlier findings (Luetterforst et al., 1999; Machleidt et al., 2000) by invoking specific
Golgi retention signals in caveolin-1. Such a model would
require that caveolin-1 contained three separate retention
signals: one in the C-terminal domain, one in the N-terminal
domain, and the third either in the N-terminal domain or the
hydrophobic domain. All three signals would be cryptic in
the intact protein, but they could be exposed by mutation.
An alternate model is that caveolin-1 must achieve the
correct conformation for efficient Golgi exit. To determine
whether Golgi accumulation might result from conformational defects, we examined a panel of caveolin-1 mutant
proteins. In addition to localization, we examined two properties of caveolin-1 that might be sensitive to conformational
changes: oligomerization and lipid raft targeting (Luetterforst et al., 1999; Machleidt et al., 2000; Lee et al., 2002).

Molecular Biology of the Cell

Caveolin-1 Mutant Proteins

Figure 3. TX100 insolubility of caveolin-1 in mixed proteoliposomes containing cellular proteins and lipids and artificial lipids.
OG lysates of COS (left) or transfected MEB-4 cells (right) were
mixed with excess OG-solubilized DPPC:cholesterol (2:1) or DOPC
as indicated, and proteoliposomes were formed by dialysis. (A)
Proteoliposomes were subjected to sucrose density gradient centrifugation (top) or were extracted with TX100 before applying to
sucrose gradients (middle and bottom). Gradients were harvested in
three fractions from the top. In each case, fraction 1 contained
floating membranes (Mem) and fraction 3 contained soluble and
detergent-solubilized proteins (Sol). Gradient pellets (Pel) contained
any aggregated proteins. (B) Proteoliposomes were extracted with
TX100 and subjected to ultracentrifugation, and the TX100-soluble
supernatant (S) and TX100-insoluble pellet (P) fractions were separated. (A and B) After resuspension and solubilization of pelleted
material, proteins in each fraction were separated by SDS-PAGE
and transferred to PVDF membranes. Caveolin-1 was detected by
Western blotting.

Figure 2. Cellular localization of caveolin-1 deletion mutant proteins. Cav-NTD (A), Cav-⌬N1/⌬C (D), or Cav-⌬N2/⌬C (G) were
detected together with endogenous GM130 (B, E, and H) in transfected FRT cells by IF. Merged images are shown in C, F, and I. In
G, arrows; lipid droplets. In J–O, PLAP was coexpressed with
wild-type caveolin-1 (J–L) or with ⌬N1/⌬C (M–O) in FRT cells.
Caveolin-1 (J) or ⌬N1/⌬C (M) was detected with mouse anti-HA
antibodies (red), and PLAP in the same cells (K and N, respectively)
with anti-PLAP antibodies (green). (L and O); merged images. Schematic diagrams of caveolin-1 and the mutant proteins, indicating
the N- and C-terminal hydrophilic domains as open boxes, and the
central hydrophobic domain as a shaded box, are shown. The
dashed line in the diagram of Cav-⌬N2/⌬C indicates a deleted
region.

A Reconstituted System for Assaying DRM Association of
Caveolin-1 Mutant Proteins
Raft affinity of membrane proteins is usually examined by
determining their association with DRMs after detergent
extraction of cells. However, as a protein’s lipid environment at the time of extraction affects DRM association
(Brown and Rose, 1992; Schroeder et al., 1998), we could not
use this method to compare the raft affinity of proteins in
different organelles. Instead, we examined DRM association
in vitro, by using a liposome reconstitution assay. We mixed
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lysates of cells expressing the mutant proteins with excess
raft-forming lipids, formed liposomes by dialysis, isolated
DRMs from the liposomes after TX100 extraction, and determined whether the mutant proteins associated with the
DRMs.
To test this system, we first showed that wild-type caveolin-1 derived from both COS and transfected MEB-4 cells
associated efficiently with liposomes, as it floated with them
in sucrose gradients (Figure 3A, top). MEB-4 cells were
chosen because they produce very little endogenous caveolin-1 (Ostermeyer et al., 1999), but they express transfected
constructs at high efficiency. About half the wild-type caveolin-1 associated with floating DRMs after Triton X-100 extraction (Figure 3A, middle). Very little caveolin-1 aggregated and pelleted in the gradients. To show that DRM
association depended on liposome lipids, and not cellular
lipids that remained associated with caveolin-1, we repeated
the assay, mixing cell lysates with DOPC, a nonraft forming
lipid. Caveolin-1 associated well with these liposomes (our
unpublished data), but was efficiently solubilized when
these liposomes were extracted with TX100 (Figure 3A, bottom).
For convenience, in later experiments, DRMs were collected as pellets rather than by flotation in sucrose gradients.
We detected ⬃70% of both endogenous COS cell caveolin-1
and wild-type caveolin-1 expressed in MEB4 cells in DRMs
by using this method (Figure 3B). We do not know why
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more caveolin-1 was present in the pellet in this assay than
floated with DRMs in sucrose gradients (Figure 3A). A small
fraction of the protein may have aggregated and may have
pelleted along with DRM-associated protein in the pelleting
assay. Aggregates may have been small and may not have
pelleted in sucrose gradients. Alternatively, some of the
DRM-associated protein may not have withstood the rigors
of sucrose gradient analysis, and may have been stripped
from DRMs during centrifugation. In any event, as described next, the pelleting assay was useful in distinguishing
qualitatively between mutants with high and low DRM
association.
Correlation between Localization, Oligomerization, and
DRM Association of Hydrophobic Domain Mutant
Proteins
We next examined the behavior of a panel of caveolin-1
mutant proteins in the three assays. Results, shown in Figures 4 –7 and summarized in Figure 8, are grouped according to the mutated protein domain. Almost all the mutant
proteins showed a striking correlation between behavior in
the three assays.
We first examined six mutant proteins in which sequential
groups of five or six residues through the hydrophobic
domain were changed to Ala (Figure 4A). Three of these
proteins (102A5, 113A5, and 130A5) were similar to wildtype caveolin-1 in all three assays. First, they had similar
localization patterns, although they were somewhat more
enriched in the Golgi apparatus than the wild-type protein
(Figure 4B). We examined oligomerization by using blue
native gel electrophoresis. In this method, after gentle cell
lysis with OG, detergent is replaced by Coomassie Blue dye,
which supplies charge to allow migration in native acrylamide gels, but does not denature proteins and can preserve
protein complexes (Schagger et al., 1994). Wild-type caveolin-1 expressed in MEB-4 cells migrated as a high-molecularweight oligomer on blue native gels (Figure 4C), as expected
from previous sucrose velocity gradient analysis (Monier et
al., 1995; Sargiacomo et al., 1995; Machleidt et al., 2000).
102A5, 113A5, and 130A5 were largely oligomeric and comigrated with the wild-type proteins, although we also saw a
fainter, faster migrating form. This was probably a monomer, because it comigrated with mutant proteins lacking the
oligomerization domain that migrate as monomers on velocity gradients (Sargiacomo et al., 1995). The same three
proteins also associated well with DRMs isolated from
mixed proteoliposomes (Figure 4D).
By contrast, the other three hydrophobic domain Ala-scan
mutant proteins, 107A5, 118A5, and 123A6, were defective
in all three assays: they were highly concentrated in the
Golgi apparatus, migrated as monomers on blue native gels,
and associated poorly with DRMs (Figure 4).
We examined three additional hydrophobic domain mutant proteins. We made the first protein (G108⫹A112)L, after
noticing that if the first half of the hydrophobic domain
formed an ␣ helix, then the helix face containing G108 and
A112 would contain only small residues (Ostermeyer et al.,
2004), suggesting that it might pack closely against another
helix (Eilers et al., 2002). We changed these residues to Leu to
determine whether their small size might be important in
structure. (G108⫹A112)L accumulated in the Golgi apparatus (Figure 5A, i), did not oligomerize properly (Figure 5B,
lane 1), and associated poorly with DRMs in the reconstitution assay (Figure 5C), supporting the idea that these residues were structurally important.
P132L, which was detected in 16% of human breast tumors (Hayashi et al., 2001), colocalized with GM130 in the
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Figure 4. Localization, oligomerization, and raft association of
caveolin-1 hydrophobic domain Ala-scan mutant proteins. (A) The
sequence of the hydrophobic domain of caveolin-1, bounded by
basic residues, is shown. Sequential groups of five or six residues,
together spanning the hydrophobic domain, were changed to Ala as
indicated. Each mutant protein was named for the position of the
first altered residue and the number of altered residues (i.e., 102A5)
or simply by the position of the first altered residue (i.e., 102). (B)
Localization of the indicated mutant proteins (green) and GM130
(red) in transfected FRT cells is shown. (C) Proteins in lysates of
MEB-4 cells expressing wild-type caveolin-1 or the indicated mutant
protein were separated by blue native gel electrophoresis and transferred to PVDF membranes. Caveolin-1 and the mutant proteins
were detected by Western blotting. Positions of molecular weight
standards (MW), detected by Coomassie Blue staining of the membrane, are shown. Exact molecular weights of membrane proteins
cannot be determined by native gel analysis. (D) Mixed proteoliposomes formed from lysates of MEB-4 cells expressing the indicated
mutant protein and excess DPPC:cholesterol (2:1) were subjected to
TX100 extraction and centrifugation. Supernatant (S) and pellet (P)
fractions were analyzed for the presence of the mutants by SDSPAGE and Western blotting.

Golgi apparatus in FRT cells (our unpublished data), as
reported previously (Lee et al., 2002). Those authors reported
that coexpression with P132L caused retention of wild-type
caveolin-1 in a perinuclear compartment in COS-7 and human mammary epithelial cells (Lee et al., 2002). By contrast,
we saw no effect of coexpression on the localization of
caveolin-1-GFP or P132L in FRT cells. Except in very highly
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Figure 5. Localization, oligomerization, and raft association of
caveolin-1 hydrophobic domain mutant proteins. (A) FRT cells expressing (G108⫹A112)L (i and iv), P110L (ii and v), or both myc/
GFP-tagged caveolin-1 and HA-tagged P132L (iii and vi) were processed for IF. i, ii, iv, and v, (G018⫹A112)L (i) and P110L (ii) were
detected together with GM130 (iv and v, respectively). iii and vi,
caveolin-1 was detected by GFP fluorescence (iii), whereas P132L
was detected with rabbit anti-HA and Texas Red goat anti-rabbit
antibodies (vi). (B) Oligomerization of the indicated proteins
[(G108⫹A112)L, labeled (GA)L; P132L; wild-type caveolin-1; and
P110, respectively] was determined on blue native gels as in Figure
4C. The smear migrating more slowly than the (G108⫹A112)L
monomer band was variable. (C) TX100-insolubility of the indicated
mutant proteins in raft-containing liposomes was determined as in
Figure 4D.

expressing cells, wild-type caveolin-1-GFP was present
largely in caveolae (Figure 5A, iii), whereas P132L had a
Golgi-like distribution (Figure 5A, vi).
P132L migrates as a monomer on sucrose velocity gradients (Lee et al., 2002). We saw two forms of P132L on
blue native gels; oligomers that migrated more slowly
than wild-type caveolin-1, and monomers (Figure 5B, lane
2). The relative amounts of the two forms varied between
experiments. These results suggested that the slowly migrating form of P132L was an abnormal oligomer that
dissociated more easily than wild-type caveolin-1. We
could not detect P132L in reconstituted liposomes. Changing the second conserved Pro residue in the hydrophobic
domain to Leu (P110L) did not affect cellular localization,
oligomerization, or detergent insolubility in the reconstitution assay (Figure 5).
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Correlation between Localization, Oligomerization, and
DRM Association of C-Terminal Domain Mutants
A series of C-terminal truncation mutant proteins (Figure
6A, arrows indicate the last residue in each protein) showed
good correlation between behavior in the three assays. ⌬13,
containing the longest C-terminal domain, had a wild-type
distribution in cells (Figure 6B) and oligomerized and associated with DRMs normally (Figure 6, C and D). ⌬21 was
somewhat more concentrated in the Golgi apparatus than
wild-type caveolin-1, although it was easily detectable in
caveolae as well (Figure 6B). This protein was mostly oligomeric and associated well with DRMs (Figure 6, C and D).
⌬31 was substantially more concentrated in the Golgi apparatus (Figure 6B), although not as completely as some other
mutants and did not oligomerize or associate well with
DRMs (Figure 6, C and D). Finally, ⌬39 and ⌬C were concentrated in the Golgi apparatus (⌬C, Figure 6B; ⌬39, our
unpublished data), as reported previously for a C-terminal
deletion mutant in Chinese hamster ovary cells (Machleidt et
al., 2000), failed to oligomerize and associated poorly with
DRMs (Figure 6, C and D). We sometimes saw a second form
of ⌬39 and ⌬C that migrated slightly more slowly than the
monomer, as seen for ⌬C in Figure 6C.
Because ⌬21 was more severely affected than ⌬31 in all
three assays, we changed either the first or second five
residues in the 10-residue sequence that distinguished these
proteins to Ala, in the context of the full-length protein. Both
of these mutant proteins (Y148A5 and H153A5, Figure 6A)
had a wild-type localization in cells (our unpublished data),
oligomerized efficiently (Figure 6C), and associated well
with DRMs (Figure 6D). For unknown reasons, oligomers of
Y148A5 and H153A5 migrated slightly faster than those of
the wild-type protein, an effect that did not depend on their
lack of a myc tag (Figure 6C). We conclude that residues
148 –157 did not contain a specific motif that directly affected
localization, oligomerization, or raft affinity. Finally, Cys-, a
nonpalmitoylated caveolin-1 mutant, was indistinguishable
from wild-type caveolin-1 in all three assays (localization
not shown; oligomerization and detergent-insolubility in
Figure 6, C and D), in agreement with previous reports
(Dietzen et al., 1995; Monier et al., 1996).
Localization, Oligomerization, and DRM Association of
N-Terminal Domain Mutants
The first three N-terminal domain mutants that we examined were defective in all three assays. ⌬CSD, which lacked
F81-Y100 (Figure 7A, left), accumulated in the Golgi apparatus (Figure 7B), failed to oligomerize, (Figure 7C, i), and
did not associate well with DRMs (Figure 7D, left). Aromatic
residues, which are abundant in the CSD, were previously
shown to aid in membrane association of a CSD peptide
(Arbuzova et al., 2000). We made two mutant proteins,
WFF/AAA and 97/SASA (Figure 7A, right), to examine the
importance of these residues. Both proteins showed the
same behavior: they accumulated in the Golgi apparatus
(97/SASA, Figure 7B; WFF/AAA, our unpublished data),
failed to oligomerize (Figure 7C, i), and associated poorly
with DRMs in the reconstitution assay (Figure 7D, left).
Thus, the CSD, and especially aromatic residues in that
domain, were important in caveolin-1 structure.
We next examined six mutant proteins in which sequential groups of five residues through the CSD and the region
just upstream of it were changed to Ala (71A75–96A100;
Figure 7A, right). Our results were largely similar to those of
Machleidt et al. (2000), who made these constructs. All the
proteins were concentrated in the Golgi apparatus, but they
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Figure 6. Localization, oligomerization,
and raft association of caveolin-1 C-terminal
domain mutant proteins. (A) Sequence of the
C-terminal domain of caveolin-1, with the
end of the hydrophobic domain indicated as
an open box, is shown. Arrows indicate the
last residue in each of a series of mutant
proteins. All proteins (except ⌬C, which
lacked the entire C-terminal domain except
K135) are named for the number of deleted
residues (i.e., ⌬13 lacked the last 13 residues
of caveolin-1, and ended with K165). Two
mutant proteins, Y148A5 and H153A5 (labeled 148 and 153, respectively, in Figure
6C), contained five Ala residues in place of
the indicated residues. Of these proteins,
only ⌬39 contained a C-terminal myc tag. (B)
The localization of the indicated mutant proteins and GM130 in transfected FRT cells is
shown. (C) Oligomerization was determined
on blue native gels as in Figure 4C. ⫺Myc,
wild-type caveolin-1 lacking the Myc tag.
Cys-, a nonpalmitoylated mutant protein
(Dietzen et al., 1995). (D) TX100-insolubility
of the indicated mutant proteins in raft-containing liposomes was determined as in Figure 4D.

were also detectable in punctate structures. 71A75 and
76A80 illustrate the range of localization patterns (Figure
7B). We saw both monomeric and oligomeric forms of all the
proteins except 96A100, which was entirely monomeric (Figure 7C, ii). 76A80 and 86A90 were largely oligomeric,
whereas a higher fraction of 71A75, 81A85, and 91A95 was
monomeric.
Oligomers of these proteins migrated more slowly than
wild-type caveolin-1 (Figure 7C, ii). To determine whether
this resulted from the respective epitope tags, we introduced
the changes present in either 71A75 or 76A80 into our caveolin-1 construct. The new mutants 71* and 76* had the same
oligomer:monomer ratio as 71A75 and 76A80, respectively
(our unpublished data). Furthermore, they comigrated with
the original mutant proteins and migrated more slowly than
wild-type caveolin-1, although they migrated faster than
P132L (Figure 7C, iii and iv, only oligomer bands shown).
71A75 and 76A80 associated well with DRMs (Figure 7D).
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81A85 and 86A90 showed intermediate and variable behavior, and 91A95 and 96A100 were mostly TX100 soluble. By
contrast, Machleidt et al. (2000) found that all these mutants
were detergent soluble when transfected cells were extracted with Triton X-100, probably because the mutants
accumulated in raft-poor Golgi membranes.
Although 91A95 and 96A100 were defective in all three
assays, behavior of the other four proteins was less consistent. We do not know the significance of the slow migration
of their oligomers. These proteins may have been borderline
cases, with slightly altered conformations that affected their
behavior in unpredictable ways.
By contrast, ⌬N1, which lacked the first half of the
N-terminal domain (G3-E48), was the only mutant protein
that showed clearly discordant behavior in the three assays.
⌬N1 accumulated in the Golgi apparatus (Figure 7B), consistent with previous reports of similar mutant proteins
(Luetterforst et al., 1999; Machleidt et al., 2000). Nevertheless,
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Figure 7. Localization, oligomerization,
and raft association of caveolin-1 N-terminal
domain mutant proteins. (A) Left, schematic
diagram of two deletion mutant proteins,
⌬CSD (lacking F81-Y100) and ⌬N1 (lacking
G3-E48). (A) Right, sequence of the last 31
residues of the N-terminal domain is shown,
with the start of the hydrophobic domain
shown as an open box. The alterations in
two substitution mutant proteins are indicated below the N-terminal domain sequence. In WFF/AAA, Ala is substituted for
each of W85, F89, and F92. In 97/SASA, the
sequence SASA is substituted for residues
Y97-Y100. The alterations in five mutant
proteins in which sequential groups of five
residues were changed to Ala are shown
above the wild-type sequence (Machleidt et
al., 2000). These proteins are named for the
first and last altered residues (i.e., 71A75
contains Ala substituted for each of residues
71–75). In Figure 7C, these proteins are indicated by the first changed residue (i.e.,
71A75 is called 71). (B) Localization of the
indicated proteins and GM130 in transfected
FRT cells is shown. (C) Oligomerization was
determined on blue native gels as in Figure
4C. Only the oligomer bands are shown in iii
and iv. 71* and 76*, substitution of Ala for
residues 71–75 or 76 – 80, respectively, in the
myc and HA-tagged wild-type caveolin-1
shown on the same blot. In iii, the amounts
of lysate loaded in each lane were varied to
obtain more uniform oligomer bands. (D)
TX100-insolubility of the indicated mutant
proteins in raft-containing liposomes was
determined as in Figure 4D.

⌬N1 oligomerized and associated with DRMs as well as
wild-type caveolin-1 (Figure 7C, v and D). Thus, oligomerization and DRM association were not sufficient for efficient
Golgi exit. Results of the behavior of the mutant proteins in
the three assays are summarized in Figure 8.
Persistence of Caveolin-1 Mutants in the Golgi Apparatus
We next determined the localization of selected mutant proteins in cycloheximide-treated cells. 97/SASA and 118A5
remained highly concentrated in the Golgi apparatus after
prolonged cycloheximide treatment (Figure 9, A–F). Golgi
localization of 102A5 and ⌬21, which were not as highly
concentrated in the Golgi apparatus at steady state, was
reduced but still detectable after 3-h cycloheximide treatment (Figure 9, G–L). By contrast, Golgi staining of ⌬31 (the
C-terminal truncation mutant that was more Golgi-enriched
than ⌬21 at steady state) was still pronounced in the Golgi
after 3-h cycloheximide treatment (Figure 9, M–O). Thus, the
concentration of caveolin-1 mutants in the Golgi apparatus
at steady state was at least partially explained by their
reduced rate of Golgi exit.
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Transport through the Secretory Pathway Is Not Required
for Oligomerization or Acquisition of Raft Affinity
Transport to the late Golgi apparatus or plasma membrane
might be necessary for acquisition of raft affinity, for instance, through a posttranslational modification or conformational change that occurred only in a late compartment.
To test this possibility, we examined Cav-KKSL, wild-type
caveolin-1 with an appended ER retrieval signal (Ostermeyer et al., 2001). As reported previously (Ostermeyer et al.,
2001), Cav-KKSL was only detectable in the ER and in
ER-derived lipid droplets (Figure 10, top), presumably
through efficient retrieval to the ER in COPI-coated vesicles.
Cav-KKSL oligomerized and associated with DRMs as well
as wild-type caveolin-1 (Figure 10, middle and bottom).
Thus, transport to late compartments of the secretory pathway was not required for oligomerization or acquisition of
raft affinity.
DISCUSSION
Golgi exit, oligomerization, and raft affinity correlated strikingly among a broad spectrum of caveolin-1 mutant pro-
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Figure 9. Persistence of caveolin-1 mutant proteins in the Golgi
apparatus after cycloheximide treatment. The localization of the
indicated proteins (A, D, G, J, and M) and GM130 (B, E, H, J, and N)
in transfected FRT cells after cycloheximide treatment for 3 h (except
cells expressing 118A5, treated for 5 h) is shown. C, F, I, L, and O;
merged anti-caveolin-1 (green) and anti-GM130 (red) images.

Figure 8. Summary of localization, oligomerization, and TX100-insolubility results. The caveolin-1 mutant proteins are diagrammed
schematically as in Figure 2A. Mutants are grouped according to the
domain altered. Mult., deletions in two domains. HydD, CTD, and
NTD, changes in the hydrophobic, C-terminal, or N-terminal domains,
respectively. Asterisks indicate substitutions. Four or more substitutions are indicated by a single larger asterisk. Column 3 (PM); efficiency
of Golgi-to-plasma membrane transport. ⫹⫹, wild-type localization;
⫹, slightly enhanced Golgi localization; ⫺, Golgi accumulation. None
of these proteins except Cav-⌬N2/⌬C accumulated predominantly in
the ER, except in highly expressing cells. Column 4 (Olig); oligomerization on blue native gels. ⫹⫹, wild-type oligomerization, with very
little monomer; ⫹, predominantly oligomeric, but some monomer;
⫹/⫺, substantial oligomer and monomer; ⫺/⫹, mostly monomer; ⫺,
no oligomer detected; *, oligomer migrated more slowly than wildtype caveolin-1. Column 5 (DRM); association with TX100-resistant
membranes after extraction of raft-containing mixed proteoliposomes.
⫹, similar to wild-type caveolin-1 (⬃70% insoluble); ⫹/⫺, about equal
amounts soluble and insoluble; ⫺, poor DRM association (⬃30% insoluble). ND, not determined.
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teins. Of 26 mutant proteins examined, nine were close to
normal in all three assays, and 14 were defective in all three.
Only two mutant proteins (71A75 and 76A80) showed abnormal oligomerization and Golgi exit, but they retained raft
affinity. ⌬N1 also convincingly broke the correlation: it oligomerized normally and associated with DRMs, but it was
defective for Golgi exit. Based on these data, normal oligomerization and raft affinity might be required for Golgi
exit, although ⌬N1 showed that neither is sufficient. Alternatively, conformational defects might affect the three properties independently.
The clearest conclusion of this work is that the conformation of caveolin-1 is highly optimized, and extremely sensitive to small changes. Even caveolin-2, which accumulates in
the Golgi apparatus and does not oligomerize normally
without caveolin-1, cannot achieve this optimized conformation on its own (Mora et al., 1999; Parolini et al., 1999).
Sequences in caveolin-1 that were sensitive to mutation were
spread among all three domains of the protein. Thus, most
of the changes probably acted indirectly, by affecting overall
conformation, and not by disrupting specific motifs.
We can speculate on how changes in a few of the mutant
proteins might have affected conformation. (G108⫹A112)L
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However, ⌬N1 accumulated in the Golgi apparatus, even
though its oligomerization and raft affinity suggested that its
conformation might not be grossly disturbed. Thus, the first
half of the N-terminal domain may be especially important
in Golgi exit. Consistent with this possibility, caveolin-1 and
caveolin-2 (which accumulates in the Golgi apparatus in the
absence of caveolin-1) show little sequence similarity in this
region.

Figure 10. Localization, oligomerization,
and raft association of Cav1-KKSL. Top, localization of Cav1-KKSL in FRT cells by IF is
shown. Round structures are lipid droplets,
as reported previously (Ostermeyer et al.,
2001). Middle, oligomerization of wild-type
caveolin-1 and Cav-KKSL was determined
on blue native gels as in Figure 4C. Bottom,
TX100-insolubility of Cav-KKSL in raft-containing liposomes was determined as in Figure 4D.

contained bulky Leu residues in place of Gly108 and A112
that may normally lie on a helix face that interacts closely
with other protein domains. Similarly, P132L was more
severely affected than 130A5, in which P132 was changed to
the smaller Ala. Proper hydrophobic domain packing interactions may be required for correct conformation, and preventing this packing may affect surface delivery, oligomerization, and raft targeting indirectly.
Aromatic residues aid in membrane binding of a CSD
peptide (Arbuzova et al., 2000) and thus may affect protein
conformation by positioning the CSD close to the membrane. WFF/AAA and 97/SASA, in which aromatic residues were specifically targeted, were more severely affected
than 81A85, 86A90, or 91A95, Ala scan mutant proteins
through the same region. Two Ala-scan mutants just upstream of the CSD, in which no aromatic residues were
changed (71A75 and 76A80), associated well with DRMs. By
contrast, all the other mutant proteins in this series had
changes in at least one aromatic residue and also had reduced DRM association. Thus, aromatic residues in the CSD
may play important and additive roles in raft targeting, as
well as overall protein conformation.
Cellular Localization
Caveolin-1 mutant proteins that lacked residues 66 –70
accumulated in the ER, supporting a previously established
role for that domain in ER exit (Machleidt et al., 2000). By
contrast, a surprising number of caveolin-1 mutant proteins
accumulated in the Golgi apparatus. Previous workers have
used a mutagenesis approach in an attempt to identify specific Golgi targeting signals in caveolin-1 (Luetterforst et al.,
1999), caveolin-2 (Breuza et al., 2002), or Golgi exit signals in
caveolin-1 (Machleidt et al., 2000). Our data suggest that
most of these alterations caused Golgi accumulation indirectly, by affecting protein conformation. Golgi accumulation of these proteins probably resulted from inhibition of
Golgi exit, rather than exposure of retention signals, as we
showed that signal-mediated Golgi retention would require
at least three separate signals.
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Golgi Transport of Caveolin-1 Is Unusually Difficult
Cargo proteins are generally transported rapidly and synchronously through the Golgi apparatus. By contrast, Golgi
passage of caveolin-1 seems to be unusually difficult. One
function of the optimized conformation of caveolin-1 may be
to partially overcome this difficulty. Disruption of this optimized conformation by mutation would then lead to Golgi
accumulation. One model explaining how this might occur
is described next.
Munro and Bretscher proposed a model to explain how
newly synthesized plasma membrane proteins in transit
through the Golgi apparatus are sorted from Golgi resident
proteins (Bretscher and Munro, 1993; Munro, 1995). Transmembrane spans of plasma membrane proteins are longer
than those of Golgi proteins. Munro and Bretscher proposed
that microdomains of different thickness coexist in the Golgi
apparatus. Cholesterol increases bilayer thickness, and they
proposed that thick domains contain more cholesterol than
thin domains. They also proposed that Golgi enzymes and
cargo proteins destined for the plasma membrane partition
into the appropriate domains according to transmembrane
domain length.
According to the cisternal maturation model of Golgi
dynamics, cargo proteins move through the Golgi apparatus
passively, as individual cisternae progress through the stack
(Pelham and Rothman, 2000; Martı́nez-Menárguez et al.,
2001; Mironov et al., 2001). This model predicts that Golgi
resident proteins, as well as any cargo proteins—like caveolin-1—that move through the Golgi more slowly than the
rate of cisternal flow, must transiently leave the cisternae,
probably in retrograde-directed recycling vesicles. To accommodate these ideas, the model of Munro and Bretscher
might predict that recycling vesicles are thinner than bulk
cisternae. Thus, long transmembrane spans of plasma membrane proteins would keep these proteins in forward-directed cisternae and prevent incorporation into retrogradedirected carriers.
Caveolin-1 lacks defined transmembrane spans. It may
not be able to sense the thickness of cholesterol-rich domains
and may not partition as strongly into these domains as
other proteins. Instead, at each sorting step, some caveolin-1
may be incorporated into retrograde-directed vesicles. The
resulting cycle would slow the net rate of forward transport.
However, caveolin-1 is transported through the Golgi apparatus faster than most of the mutants we examined and thus
may partition better into thick domains than they do. Caveolin-1 may recognize some other property of these domains,
rather than their thickness. This property may be shared
with membrane rafts. This property might be the cholesterol-induced increase in acyl-chain packing found in rafts (Xu
and London, 2000), or some other feature of the higher
cholesterol concentration. In any case, the same structural
features that target caveolin-1 to rafts also may increase its
affinity for cholesterol-rich Golgi domains. Mutants with
reduced raft affinity may have lower affinity for these domains, enhancing their incorporation into retrograde vesicles, and thus their Golgi accumulation.
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This model also could explain slow Golgi transport of
some other proteins. Like caveolins, peripheral membrane
proteins that are transported to the plasma membrane via
the secretory pathway cannot be sorted in the Golgi based
on transmembrane span length. Palmitoylation of several of
these proteins is required for efficient Golgi exit (Choy et al.,
1999; Kanaani et al., 2002; Navarro-Lérida et al., 2002; Takimoto et al., 2002; Takida and Wedegaertner, 2003). Palmitoylation can target proteins to rafts (Brown and London,
2000) and thus also might sort these proteins into cholesterol-rich Golgi domains in the Golgi. Palmitoylation also enhances Golgi transport of some transmembrane proteins
(van’t Hof and Crystal, 2002; Kalinina and Fricker, 2003),
possibly through the same mechanism.
Three caveolin-1 mutants, 71A75, 76A80, and ⌬N1, did
not fit this model. They had apparently normal raft affinity
but accumulated in the Golgi apparatus. It is possible that
the sensitivity of our DRM assay is not high enough to detect
small changes in raft affinity that are important in vivo.
It is also possible that Golgi accumulation of caveolin-1
mutants is related to quality control, a process of recognition
and degradation of misfolded proteins. Many of the mutant
proteins that we examined were degraded rapidly, as reported previously (Machleidt et al., 2000). Golgi accumulation of misfolded caveolin-1 mutant proteins might occur as
part of a post-ER quality control system.
Caveolin-1 Oligomerization
Blue native gel analysis gave some new insights into caveolin-1 oligomerization. We saw remarkably few intermediate
sized oligomers. We occasionally saw a band that migrated
slightly more slowly than the monomer, when examining
mutants that were otherwise entirely monomeric. Some mutants were present in both monomeric and oligomeric forms,
suggesting that oligomerization was inefficient or oligomers
unstable. However, we never saw any other intermediatesized forms of these proteins. This suggested that oligomerization of caveolin-1 is highly cooperative.
A few mutant proteins oligomerized, but did not quite
comigrate with wild-type caveolin-1 on blue native gels.
These complexes may contain different numbers of monomers, or may have a different shape or ability to bind dye.
These mutants also may bind differentially to other proteins,
although caveolin-1 oligomers are thought to contain no
additional proteins except caveolin-2 (Monier et al., 1995;
Scheiffele et al., 1998). Oligomers of Y148A5 and H135A5
migrated slightly faster than wild-type caveolin-1. These
mutant proteins oligomerized as efficiently as wild-type
caveolin-1 and showed normal cellular localization and
DRM association. This suggested that their abnormal migration on blue native gels reflected only minor conformational
changes.
Two classes of mutant proteins formed oligomers that
migrated unusually slowly. P132L was the only member of
the first class. The other class included six Ala-scan mutants
in and near the CSD (Figure 7), and also a W85A point
mutant (our unpublished data). As all these oligomers were
similarly affected, changes throughout this region seemed to
cause the same structural alteration. P132L oligomers migrated more slowly than those of the CSD mutants. Oligomers of both classes migrated as distinct bands, suggesting that they did not aggregate nonspecifically. We saw
significant amounts of monomeric forms of all these mutant
proteins, suggesting that oligomerization was inefficient or
unstable. All these mutant proteins accumulated in the Golgi
apparatus. Thus, structural changes that reduced oligomer
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mobility seemed to affect caveolin-1 conformation more severely than those that increased migration.
The correlation between in vitro DRM association and
oligomerization suggested that wild-type caveolin-1 and oligomerization-competent mutant proteins were probably incorporated into liposomes as oligomers. Blue native gel analysis showed that the wild-type protein remained oligomeric
after reconstitution (our unpublished data), and we expect
that this was true of the mutant proteins as well.
Further work will clearly be required to fully understand
how so many different mutations can alter the conformation
of caveolin-1 and how these changes can have such profound effects on Golgi exit, oligomerization, and raft affinity
of the protein.
ACKNOWLEDGMENTS
We thank S. Munro (Medical Research Council) and P. Liu and R.G.W.
Anderson (University Texas Southwestern Medical College) for plasmids.
This work was supported by grants GM-47897 (to D.A.B.) and GM-41297 (to
D.M.L.) from the National Institutes of Health.

REFERENCES
Arbuzova, A., Wang, L., Wang, J., Hangyas-Mihalyne, G., Murray, D., Honig,
B., and McLaughlin, S. (2000). Membrane binding of peptides containing both
basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS.
Biochemistry 39, 10330 –10339.
Arreaza, G., and Brown, D.A. (1995). Sorting and intracellular trafficking of a
glycosylphosphatidylinositol-anchored protein and two hybrid proteins with
the same ectodomain in MDCK kidney epithelial cells. J. Biol. Chem. 270,
23641–23647.
Bretscher, M.S., and Munro, S. (1993). Cholesterol and the Golgi apparatus.
Science 261, 1280 –1281.
Breuza, L., Corby, S., Arsanto, J.-P., Delgrossi, M.-H., Scheiffele, P., and Le
Bivic, A. (2002). The scaffolding domain of caveolin 2 is responsible for its
Golgi localization in Caco-2 cells. J. Cell Sci. 115, 4457– 4467.
Brown, D.A., and London, E. (2000). Structure and function of sphingolipidand cholesterol-rich membrane rafts. J. Biol. Chem. 275, 17221–17224.
Brown, D.A., and Rose, J.K. (1992). Sorting of GPI-anchored proteins to
glycolipid-enriched membrane subdomains during transport to the apical cell
surface. Cell 68, 533–544.
Choy, E., Chiu, V.K., Silletti, J., Feoktistov, M., Morimoto, T., Michaelson, D.,
Ivanov, I.E., and Philips, M.R. (1999). Endomembrane trafficking of Ras: the
CAAX motif targets proteins to the ER and Golgi. Cell 98, 69 – 80.
Conrad, P.A., Smart, E.J., Ying, Y.-S., Anderson, R.G.W., and Bloom, G.S.
(1995). Caveolin cycles between plasma membrane caveolae and the Golgi
complex by microtubule-dependent and microtubule-independent steps.
J. Cell Biol. 131, 1421–1433.
Denker, S.P., McCaffrey, J.M., Palade, G.E., Insel, P.A., and Farquhar, M.G.
(1996). Differential distribution of ␣ subunits and ␤␥ subunits of heterotrimeric G proteins on Golgi membranes of the exocrine pancreas. J. Cell Biol.
133, 1027–1040.
Dietzen, D.J., Hastings, W.R., and Lublin, D.M. (1995). Caveolin is palmitoylated on multiple cysteine residues: palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem. 270, 6838 – 6842.
Dupree, P., Parton, R.G., Raposo, G., Kurzchalia, T.V., and Simons, K. (1993).
Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J.
12, 1597–1605.
Eilers, M., Patel, A.B., Liu, W., and Smith, S.O. (2002). Comparison of helix
interactions in membrane and soluble alpha-bundle proteins. Biophys. J. 82,
2720 –2736.
Fernandez, I., Ying, Y., Albanesi, J., and Anderson, R.G.W. (2002). Mechanism
of caveolin filament assembly. Proc. Natl. Acad. Sci. USA 99, 11193–11198.
Fra, A.M., Williamson, E., Simons, K., and Parton, R.G. (1994). Detergentinsoluble glycolipid microdomains in lymphocytes in the absence of caveolae.
J. Biol. Chem. 269, 30745–30748.
Hayashi, K., Matsuda, S., Machida, K., Yamamoto, T., Fukuda, Y., Nimura, Y.,
Hayakawa, T., and Hamaguchi, M. (2001). Invasion activating caveolin-1
mutation in human scirrhous breast cancers. Cancer Res. 61, 2361–2364.

Molecular Biology of the Cell

Caveolin-1 Mutant Proteins
Kalinina, E.V., and Fricker, L.D. (2003). Palmitoylation of carboxypeptidase D.
Implications for intracellular trafficking. J. Biol. Chem. 278, 9244 –9249.
Kanaani, J., el-Husseini Ael, D., Aguilera-Moreno, A., Diacovo, J.M., Bredt,
D.S., and Baekkeskov, S. (2002). A combination of three distinct trafficking
signals mediates axonal targeting and presynaptic clustering of GAD65. J. Cell
Biol. 158, 1229 –1238.
Kurzchalia, T.V., Dupree, P., Parton, R.G., Kellner, R., Virta, H., Lehnert, M.,
and Simons, K. (1992). VIP21, a 21-kD membrane protein, is an integral
component of trans-Golgi-network-derived transport vesicles. J. Cell Biol. 118,
1003–1014.
Lee, H., Park, D.S., Razani, B., Russell, R.G., Pestell, R.G., and Lisanti, M.P.
(2002). Caveolin-1 mutations (P132L and null) and the pathogenesis of breast
cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and
caveolin-1 (⫺/⫺) null mice show mammary epithelial cell hyperplasia. Am. J.
Pathol. 161, 1357–1369.
Lipardi, C., Mora, R., Colomer, V., Paladino, S., Nitsch, L., Rodriguez-Boulan,
E., and Zurzolo, C. (1998). Caveolin transfection results in caveolae formation
but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells. J. Cell Biol. 140, 617– 626.
London, E., and Brown, D.A. (2000). Insolubility of lipids in Triton X-100.
Physical origin and relationship to sphingolipid/cholesterol domains (rafts).
Biochim. Biophys. Acta 1508, 182–195.
Luetterforst, R., Stang, E., Zorzi, N., Carozzi, A., Way, M., and Parton, R.G.
(1999). Molecular characterization of caveolin association with the Golgi
complex: identification of a cis-Golgi targeting domain in the caveolin molecule. J. Cell Biol. 145, 1443–1460.
Machleidt, T., Li, W.-P., Liu, P., and Anderson, R.G.W. (2000). Multiple
domains in caveolin-1 control its intracellular traffic. J. Cell Biol. 148, 17–28.
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